Opal Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$943K Buy
786
+7
+0.9% +$7.15K 0.2% 56
2026
Q1
$717K Buy
779
+5
+0.6% +$5.07K 0.16% 67
2025
Q4
$832K Sell
774
-5
-0.6% -$4.78K 0.22% 60
2025
Q3
$594K Sell
779
-412
-35% -$307K 0.17% 77
2025
Q2
$928K Buy
1,191
+228
+24% +$177K 0.26% 44
2025
Q1
$795K Sell
963
-53
-5% -$44.1K 0.25% 45
2024
Q4
$784K Buy
1,016
+100
+11% +$82.8K 0.24% 58
2024
Q3
$812K Buy
916
+99
+12% +$89K 0.25% 53
2024
Q2
$740K Buy
817
+23
+3% +$18.4K 0.24% 53
2024
Q1
$618K Buy
794
+56
+8% +$39.9K 0.21% 67
2023
Q4
$430K Buy
738
+32
+5% +$18.7K 0.17% 89
2023
Q3
$379K Buy
706
+62
+10% +$31.9K 0.22% 77
2023
Q2
$302K Sell
644
-46
-7% -$19.3K 0.15% 93
2023
Q1
$237K Buy
+690
New +$233K 0.14% 97

Other funds holding LLY

Opal Wealth Advisors's LLY Position: Q2 2026 in Review

Opal Wealth Advisors increased its Eli Lilly (LLY) stake by 0.9% in Q2 2026, buying an estimated $7.15K and bringing the position to 786 shares worth $943K. The position accounts for 0.2% of the portfolio, ranked #56.

Opal Wealth Advisors first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Opal Wealth Advisors held 786 shares of Eli Lilly worth $943K as of Q2 2026.
  • Opal Wealth Advisors bought 7 Eli Lilly shares in Q2 2026, an estimated $7.15K.
  • Eli Lilly made up 0.2% of Opal Wealth Advisors's portfolio in Q2 2026, its #56 holding.
  • Opal Wealth Advisors first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Opal Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.